Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man.
D000328:Adult; D001095:Arachidonic Acids / Q000097:blood; D001241:Aspirin / Q000494:pharmacology; D002245:Carbon Dioxide / Q000494:pharmacology*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D011464:Epoprostenol / Q000096:biosynthesis; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011448:Prostaglandin Antagonists / Q000494:pharmacology*
D001095:Arachidonic Acids; D005230:Fatty Acids, Nonesterified; D011448:Prostaglandin Antagonists; D002245:Carbon Dioxide; D009288:Naproxen; D011464:Epoprostenol; D001241:Aspirin; D010100:Oxygen; D007213:Indomethacin